Auro Laboratories Limited (BOM:530233)
239.25
+4.15 (1.77%)
At close: Nov 17, 2026
Auro Laboratories Revenue
Auro Laboratories had revenue of 141.77M INR in the quarter ending September 30, 2026, with 60.43% growth. This brings the company's total for the last twelve months to 407.90M, up 83.84% year-over-year. In the fiscal year ending March 31, 2026, Auro Laboratories had annual revenue of 307.40M with 60.74% growth. That makes Auro Laboratories the 40,460th largest company in the world by revenue and 3,951st in India.
Revenue (ttm)
407.90M
Revenue Growth
+83.84%
P/S Ratio
3.66
Revenue / Employee
5.23M
Employees
78
Market Cap
1.49B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 307.40M | 116.16M | 60.74% |
| Mar 31, 2025 | 191.24M | -345.11M | -64.34% |
| Mar 31, 2024 | 536.35M | 7.41M | 1.40% |
| Mar 31, 2023 | 528.94M | 20.28M | 3.99% |
| Mar 31, 2022 | 508.66M | -33.86M | -6.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.20B |
| Resonance Specialties | 1.14B |
| Smruthi Organics | 1.12B |
| Panchsheel Organics | 1.10B |
| Kimia Biosciences | 1.04B |
| Tyche Industries | 503.78M |
| Accretion Nutraveda | 489.95M |
| Himalaya Nutravedics India | 430.68M |
Auro Laboratories News
- 1 year ago - Shaan Jain resigns as CFO of Auro Laboratories, effective December 18, 2024 - Business Upturn